Health
Single dose of 'magic mushrooms' provides 5 years of depression relief, researchers find
NEWYou can now listen to Fox News articles!
Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after just one dose, according to a new study.
The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, followed up with patients who had been diagnosed with clinical depression — also known as major depressive disorder (MDD) — and had participated in a previous psilocybin treatment study in 2020.
“Most people who participated in our trial reported improvements in depression symptom intensity or in the ways in which they experienced depression in their life, lasting up to five years after the trial,” study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Fox News Digital.
PSYCHEDELICS AS POTENTIAL MENTAL HEALTH TREATMENT ARE EXPLORED BY TRUMP ADMINISTRATION
Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin in Toronto, Ontario, told Fox News Digital that the outcome speaks to the “exciting” potential of psilocybin and other psychedelic-based treatments in treating MDD and other mental health conditions.
“The results of the study are certainly very encouraging,” said Drysdale, who was not involved in the study.
A worker holds dried psychedelic mushrooms. The results of the new study are “certainly very encouraging,” said one pharmaceutical company executive. (James MacDonald/Bloomberg via Getty Images)
Earlier studies pointed toward the possibility of psilocybin as a potential antidepressant, prompting researchers to conduct the first-ever randomized clinical trial.
The initial 2020 trial, published in JAMA Psychiatry, included 24 patients with major depressive disorder. Half received psilocybin at the beginning of the trial, and the other half received the treatment eight weeks later.
Each patient also underwent 11 hours of psychotherapy.
WHAT IS KETAMINE THERAPY? MORMON REALITY STARS TOUT CONTROVERSIAL TREATMENT
One month after treatment, 17 patients reported experiencing symptom relief. Fourteen of those reported full remission from depression, according to the published study.
“The effectiveness of psilocybin therapy after a single or only a few administrations represents another substantial advantage over commonly used antidepressants that require daily administration,” the researchers wrote.
Patients appeared to respond much faster to psychedelics than to traditional antidepressants, the researchers stated. (James MacDonald/Bloomberg via Getty Images)
The new study aimed to explore the longer-term effects of this treatment on 21 of the original trial participants.
Sixty-seven percent reported being in remission from depression five years after treatment, and they also had less anxiety and easier daily functioning.
“The study doesn’t account for naturalistic changes that could have affected their depression in the five years since the main trial.”
For those whose depression came back, many still reported lasting benefits in their attitudes, perspectives and ability to pursue things that were meaningful to them, Davis told Fox News Digital.
“Certainly, more controlled and rigorous study is required, but at least anecdotally, these findings are very interesting, and I am cautiously optimistic about the potential for extended efficacy provided by these types of treatments,” Drysdale added.
Sixty-seven percent of participants reported being in remission from depression five years after treatment, and they also had less anxiety and easier daily functioning. (JASON CONNOLLY/AFP via Getty Images)
Other factors may have also played a role in the participants’ long-term mental health benefits, such as psychotherapy sessions or other antidepressants, experts agreed.
“The study doesn’t account for naturalistic changes that could have affected their depression in the five years since the main trial, and the sample is not representative of the population of people suffering with depression,” Davis told Fox News Digital.
PARKINSON’S PATIENTS WHO TAKE ‘MAGIC MUSHROOMS’ SEE KEY BENEFITS, STUDY FINDS
Psilocybin has also been explored as a potential treatment for post-partum depression (PPD), which affects as many as one in seven new mothers.
A 2022 study outlined the potential role of psychedelics in PPD cases, finding that psilocybin has been shown to catalyze a sense of “reconnection” in new mothers.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“This effect in PPD, by fostering a sense of ‘reconnection’ for the mother, may allow for improved mood and maternal sensitivity toward the infant, which can positively impact maternal role gratification and the mother-infant relationship,” the researchers stated.
In February, Cleveland Clinic reported on an upcoming study that explores single-dosing psilocybin as a way to treat PPD.
Psilocybin has been explored as a potential treatment for post-partum depression (PPD), which affects as many as one in seven new mothers. (iStock)
The trial, now in its second phase, focuses on RE104, a proprietary drug similar to psilocybin.
Study participants will undergo multiple physical and mental health tests.
Potential risks and limitations
Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, has emphasized the importance of administering psychedelics in a safe setting when treating mental health conditions.
For more Health articles, visit www.foxnews.com/health
“Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia,” Moss previously told Fox News Digital.
Experts recommend that therapeutic use of psychedelics should be carefully managed by medical experts.
“Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials.”
To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions.
Other factors may have also played a role in the participants’ long-term mental health benefits, noted an expert (not pictured), such as psychotherapy sessions or other antidepressants. (iStock)
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News’ senior medical analyst, previously interviewed two of the country’s top researchers on psychedelics: Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone.
“They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses,” Siegel told Fox News Digital at the time.
“Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts,” Siegel added.
Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed reporting.
Health
Common gym supplement could help fight depression, new research suggests
NEWYou can now listen to Fox News articles!
Creatine, the common muscle-building supplement, may help improve depression symptoms, new research suggests.
A systematic review, published in Genomic Press’ Brain Medicine, found that creatine monohydrate may be beneficial as an add-on treatment for major depressive disorder, although the evidence remains preliminary.
The Canada-based researchers analyzed data from five randomized controlled trials, evaluating the impact of creatine monohydrate intake on mental health.
AMERICANS ARE GIVING UP MULTIVITAMINS FOR A DIFFERENT DAILY HEALTH HABIT, STUDY FINDS
Four of the trials studied major depressive disorder, and another looked at bipolar disorder with a current depressive episode.
In one trial of women with depression who took 5 grams of creatine per day, plus the antidepressant escitalopram, there was greater improvement after eight weeks. Another study revealed benefit when creatine was added to cognitive behavioral therapy.
One study saw benefit when creatine was added to cognitive behavioral therapy. (iStock)
Other studies involving teen girls found no benefit from a variety of creatine dosages after eight weeks. The bipolar depression study also found no significant improvements when 6 grams of creatine was added to medication after six weeks.
COMMON VITAMIN MAY INFLUENCE BRAIN AGING IN WAYS SCIENTISTS DIDN’T EXPECT
In a press release, the researchers said previous studies have found that people with mood disorders process creatine differently in the brain. Because creatine helps produce energy, some scientists believe disruptions in this process may contribute to depression.
Although creatine has also been associated with boosting dopamine and serotonin, which most antidepressants target, the authors stressed that the link between brain creatine and mood “remains correlational,” as depression has “many moving parts.”
FINDING THE SLEEP ‘SWEET SPOT’ COULD HELP YOU LIVE LONGER, STUDY SUGGESTS
Lead study author Bassam Jeryous Fares, a student in the Faculty of Medicine at the University of Ottawa, commented in a statement that the signal is “interesting, but not a verdict.”
“Two trials pointed one way and three pointed another,” he said. “That is not the kind of evidence on which you change clinical practice. It is the kind that tells you the question is worth further exploration.”
Although creatine has also been associated with boosting dopamine and serotonin, which most antidepressants target, the authors stressed that the link between brain creatine and mood “remains correlational.” (iStock)
Nicholas Fabiano, corresponding author and a psychiatry resident at the University of Ottawa, added in the same press release that creatine “appears to be a safe intervention,” noting that side effects were limited to mild stomach pain.
“We cannot yet reliably say that creatine helps with depressive symptoms or if the findings are generalizable to everyone,” he added as a caveat.
CLICK HERE FOR MORE HEALTH STORIES
Dr. Thea Gallagher, psychologist and director of wellness programs at NYU Langone, said that although creatine is best known for supporting muscle performance, it also helps the brain produce and use energy.
“Researchers believe that some people with depression may have alterations in brain energy metabolism, and creatine could help support these energy-producing pathways,” Gallagher, who was not involved in the study, told Fox News Digital. “There is also emerging evidence that it may influence neurotransmitters and reduce oxidative stress and inflammation, although these mechanisms are still being investigated.”
Creatine should be considered a “promising addition” to depression treatments, a doctor said. (iStock)
The research suggests that creatine may be most helpful when combined with established depression treatments rather than as a replacement, Gallagher emphasized.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“This research is encouraging because it adds to a growing body of evidence suggesting that supporting brain energy metabolism may be another pathway for improving depression symptoms,” she said.
“It’s exciting whenever we identify another potential tool that could complement existing treatments, particularly one that is relatively inexpensive and widely available.”
Limitations and caveats
The new study is a review of prior research rather than a new clinical trial, which can pose a limitation, the researchers acknowledged, adding that “larger, well-controlled trials are still needed.”
Gallagher noted that creatine should be considered as a potentially promising addition to treatment, rather than a substitute for psychotherapy, antidepressant medication, regular exercise or healthy sleep habits.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“While creatine has a strong safety profile for most healthy adults, it’s still important to talk with your healthcare provider before starting any supplement — particularly if you have kidney disease, are pregnant or have other medical conditions,” she advised.
For those experiencing signs of depression, Gallagher recommends seeking evidence-based mental healthcare.
“While creatine has a strong safety profile for most healthy adults, it’s still important to talk with your healthcare provider before starting any supplement – particularly if you have kidney disease, are pregnant or have other medical conditions,” a doctor advised. (iStock)
The doctor noted that depression is a “highly heterogeneous condition, so we still don’t know which patients are most likely to benefit or what the optimal treatment approach looks like.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Gallagher also cautioned that supplements have been known to generate “early enthusiasm” before larger studies have revealed “more modest effects.”
“Right now, I’d describe creatine as promising but not definitive,” she concluded. “It’s an area that deserves continued research, but it’s not something people should view as a standalone treatment for depression.”
Health
Experimental vaccine shows promise against dangerous intestinal illness
NEWYou can now listen to Fox News articles!
A decades-long effort to develop a vaccine against one of the world’s leading causes of severe digestive illness has reached a milestone, according to new research.
Scientists recently developed a technology targeting enterotoxigenic Escherichia coli (ETEC), a bacterium responsible for millions of diarrheal illnesses each year.
The technology has now been licensed to French vaccine manufacturer Valneva for further development.
MYSTERY PARASITE LEAVES AMERICANS BATTLING ‘EXPLOSIVE’ ILLNESS AS CDC INVESTIGATES
The findings come after decades of research led by scientists at the University of Bergen and the Norwegian Research Center (NORCE).
One of the most common bacterial causes of severe diarrhea worldwide, ETEC is known to disproportionately affect children in low- and middle-income countries. Despite years of research, there is currently no broadly effective vaccine to prevent the infection, according to the study.
Researchers have made a major breakthrough in the decades-long effort to develop a vaccine against ETEC, a leading cause of diarrheal disease worldwide. (iStock)
The researchers focused on a toxin produced by ETEC that has long been considered one of the biggest obstacles to vaccine development.
CLICK HERE FOR MORE HEALTH STORIES
James Fleckenstein, MD, a professor of medicine and molecular microbiology at the Washington University School of Medicine in St. Louis, said the findings represent a promising step.
“We still have a lot of work to do to translate these findings to an actual vaccine,” Fleckenstein, who was not involved in the research, told Fox News Digital. “But the approach does look promising in the sense that the proteins elicit strong antibody responses that appear to offer protection against diarrheal illness after the first infection in children in developing countries.”
ETEC is a leading bacterial cause of severe diarrhea worldwide, especially among children in low- and middle-income countries. (iStock)
If the vaccine eventually reaches patients, researchers hope it could help protect children against some of the most severe forms of diarrheal disease caused by ETEC.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
In the meantime, Fleckenstein said travelers can take steps to reduce their risk of diarrheal illnesses. He recommends avoiding high-risk foods — including meals from street vendors in areas where sanitation may be poor — drinking bottled water in higher-risk regions, and practicing good hand hygiene.
While a vaccine is still years away, experts recommend avoiding high-risk foods, drinking bottled water and washing your hands to reduce the risk of ETEC. (iStock)
Fleckenstein also noted that vaccines are available to protect against typhoid fever, and said travelers should consult their physician before traveling internationally.
The research did have some limitations, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The technology is still in development and has not yet been tested as an approved vaccine among the public.
While the licensing agreement allows Valneva to continue advancing the research, additional laboratory studies, clinical trials and regulatory review will be required before the vaccine becomes available.
Health
Biohacker hoping to live to 160 reveals alarming diagnosis: ‘My stomach is eating itself’
NEWYou can now listen to Fox News articles!
Bryan Johnson, a biohacker and longevity guru who has claimed “we may be the first generation who won’t die,” revealed he has an autoimmune condition causing his stomach to “eat itself.”
The Los Angeles-based tech entrepreneur, 48, has previously shared publicly that he is hoping to live until the year 2140, when he would in theory be 160 years old.
Now, Johnson says he has been diagnosed with autoimmune gastritis (AIG), a chronic autoimmune disease in which the immune system attacks the stomach’s acid-producing parietal cells, reducing stomach acid and impairing vitamin B12 absorption, according to Nature Reviews Disease Primers.
HOW A 93-YEAR-OLD SOCCER REFEREE CREDITS WARTIME RATIONS AND DISCIPLINE FOR HIS LONGEVITY
“My stomach is eating itself,” he wrote in an Instagram post. Johnson also shared that anywhere from 2% to 5% of people likely have this disease.
“I’m going to try to solve it,” Johnson went on. “Will share all.”
Bryan Johnson, a biohacker and longevity guru who has claimed “we may be the first generation who won’t die,” revealed he has an autoimmune condition causing his stomach to “eat itself.” (Getty Images)
The biohacker shared that as a child, he ate sugary cereal, drank sugary soda and “gobbled down fast food.”
“I became a young father of three and began building a business,” Johnson went on. “Juggling that stress and grind, I let my health slip and gained 40 lbs. Within a few years I’d fallen into a deep, chronic depression.”
DOCTORS SAY 8 FORGOTTEN HABITS COULD HELP FIGHT STRESS, OBESITY AND CHRONIC DISEASE
“Somewhere in that timeline, my body began developing an autoimmune process affecting my thyroid and then my stomach lining,” he added.
Fox News Digital reached out to Johnson for comment.
AIG can remain hidden and can be challenging to diagnose, Johnson noted, often surfacing years after damage has already occurred to the stomach. It can cause iron deficiency, B12 deficiency and anemia, and can also increase the risk of stomach cancer, the expert warned.
“Low iron stores get normalized and rarely investigated at all when anemia hasn’t shown up yet,” Johnson wrote. “That blind spot is what hid mine for a decade.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
He also shared that for 11 years, he has had low levels of ferritin, a protein that stores iron inside the body’s cells. Ferritin releases iron when the body needs it, supports muscle function and carries out other essential processes.
“We continually tried to raise my iron levels with food and supplementation, but nothing would work,” he said.
The Los Angeles-based tech entrepreneur, 48, has previously shared publicly that he is hoping to live until the year 2140. (Getty Images)
Johnson acknowledged that some common biohacking techniques — including hard training, sauna and hyperbaric oxygen — all raise the body’s demand for iron.
“But none of them explained the core failure: Despite me taking iron orally, trailing every formulation and using every timing trick, none of the iron would stick.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Johnson underwent a colonoscopy and upper endoscopy, which examined his entire intestinal tract. Five biopsies were also taken from his stomach, which found “clear signs of early autoimmune gastritis: early atrophy confined to the acid-producing lining.”
In January 2026, the biohacker stated in a post on his website that “by 2039, my goal is immortality.”
“In the age of AI, multiomics, and custom-built DNA, proteins and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today’s stack,” Johnson said in his post. (Getty Images)
He detailed his strategy for defying aging, which includes embracing a strict regimen to slow or stop biological aging, using AI to accelerate longevity research, testing new treatments in lab-grown cells and organs, and reaching “longevity escape velocity” — in which medical advances would eventually extend lifespan faster than he ages.
CLICK HERE FOR MORE HEALTH STORIES
“I may fail at this task, but my team and I will try our best,” he wrote at the time.
There is currently no cure for AIG, which Johnson said he wants to change.
Johnson acknowledged that some common biohacking techniques — including hard training, sauna and hyperbaric oxygen — all raise the body’s demand for iron. (iStock)
“In the age of AI, multiomics, and custom-built DNA, proteins and cells, no condition should be presumed incurable simply because no one has yet tried to cure it with today’s stack.”
Johnson ended his post by urging others to prioritize their health.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Care for yourself, care for others, care for the planet and care for our animal friends. Care for life, as it’s the most precious gift there is.”
The longevity guru also shared an image showing the detailed findings of his five stomach biopsies.
-
Lifestyle2 minutes ago10 new books you won’t want to miss in July
-
Technology12 minutes agoDiscord accidentally banned over 8,000 people for posting grids and other ‘benign’ images
-
World17 minutes agoVideo shows bomb rock Damascus hotel where French President Macron is staying during Syrian state visit
-
Politics24 minutes agoTrump could hand prized stealth jets to NATO ally once seen as alliance headache
-
Health27 minutes agoCommon gym supplement could help fight depression, new research suggests
-
Sports32 minutes agoSJSU was told of decades-old allegations against volleyball coach during controversial 2024 season
-
Business42 minutes agoCommentary: How right-wing anti-transgender attacks led to a Supreme Court ruling upholding sex discrimination
-
Entertainment47 minutes agoEven if you know his crowd work clips and not his name, comedian Jeff Arcuri is ready to meet you